Idorsia has extended its cash runway into 2025 via an exclusivity fee for global rights negotiations for Tryvio.

In an advancement for diabetes management, the US Food and Drug Administration (FDA) has granted clearance to Medtronic’s new ...

Acadia Pharmaceuticals has secured an exclusive global licence from Saniona to develop and commercialise SAN711.

Arrowhead has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics for rare genetic disease ...

Eton has acquired the rights in the US to Amglidia for neonatal diabetes mellitus, from French biotechnology company AMMTeK.

The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the ...

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Roche has signed an agreement to acquire Poseida Therapeutics in a $1.5bn deal. The transaction includes Poseida's clinical ...

The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer ...

The biopharmaceutical industry is being called to take its sustainability efforts to the next level. A new report sheds light ...

PCI Pharma Services is a winner in the Innovation and Business Expansion categories in the 2024 Pharmaceutical Technology ...